Because SPARC affects multiple downstream signaling pathways, such as PI3K/AKT [11], in our study we focused on its potential role as a tumor suppressor protein in CML cells. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.